Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,706 | 120 | 66.5% |
| Travel and Lodging | $900.94 | 5 | 22.1% |
| Education | $462.69 | 9 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,163 | 14 | $0 (2023) |
| Astellas Pharma US Inc | $826.34 | 41 | $0 (2024) |
| NeoTract Inc. | $588.11 | 2 | $0 (2018) |
| Sumitomo Pharma America, Inc. | $193.13 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $149.01 | 10 | $0 (2024) |
| Olympus America Inc. | $142.14 | 3 | $0 (2024) |
| Boston Scientific Corporation | $125.28 | 6 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $122.36 | 7 | $0 (2023) |
| ABBVIE INC. | $111.19 | 7 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $105.67 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.47 | 17 | Endo USA, Inc. ($102.05) |
| 2023 | $529.33 | 24 | Astellas Pharma US Inc ($154.45) |
| 2022 | $1,172 | 15 | Medtronic, Inc. ($1,095) |
| 2021 | $111.90 | 7 | Astellas Pharma US Inc ($55.56) |
| 2020 | $369.45 | 14 | Astellas Pharma US Inc ($282.02) |
| 2019 | $391.23 | 25 | Astellas Pharma US Inc ($180.27) |
| 2018 | $778.98 | 15 | NeoTract Inc. ($588.11) |
| 2017 | $365.12 | 17 | Olympus America Inc. ($108.96) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $26.46 | General |
| Category: UROLOGY | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Urology | ||||||
| 08/28/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: UROLOGY | ||||||
| 08/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: HORMONE THERAPY | ||||||
| 05/29/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: UROLOGY | ||||||
| 05/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Olympus America Inc. | OES CYSTONEPHROFIBERSCOPE (Device) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Urology Gynecology | ||||||
| 04/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Oncology | ||||||
| 03/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: HORMONE THERAPY | ||||||
| 03/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Oncology | ||||||
| 03/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Oncology | ||||||
| 11/20/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/06/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: UROLOGY | ||||||
| 10/24/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Urology | ||||||
| 09/19/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Urology | ||||||
| 09/13/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,405 | 3,259 | $765,181 | $193,089 |
| 2022 | 29 | 2,544 | 3,534 | $834,597 | $211,072 |
| 2021 | 30 | 2,820 | 3,915 | $891,997 | $232,988 |
| 2020 | 28 | 2,857 | 3,885 | $819,588 | $217,488 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 40 | 355 | $225,248 | $47,697 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 472 | 596 | $114,217 | $31,654 | 27.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 179 | 201 | $96,279 | $28,174 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 136 | $38,526 | $11,199 | 29.1% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 20 | 20 | $39,840 | $10,559 | 26.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 31 | 33 | $28,800 | $10,413 | 36.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 52 | 52 | $27,456 | $8,602 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $32,588 | $7,356 | 22.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 60 | 60 | $18,000 | $5,834 | 32.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 50 | $15,700 | $4,774 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 34 | $13,155 | $3,938 | 29.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 15 | 16 | $9,200 | $3,647 | 39.6% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2023 | 26 | 26 | $8,514 | $3,117 | 36.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 225 | 269 | $3,228 | $2,260 | 70.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 50 | 50 | $20,350 | $2,131 | 10.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 672 | 906 | $11,778 | $1,952 | 16.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 20 | $24,364 | $1,833 | 7.5% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 12 | 12 | $5,776 | $1,758 | 30.4% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 12 | 38 | $4,894 | $1,347 | 27.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 38 | 54 | $4,320 | $1,179 | 27.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 29 | $2,668 | $1,049 | 39.3% |
| 55876 | Placement of device in prostate for radiation therapy | Facility | 2023 | 24 | 24 | $7,680 | $904.80 | 11.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,609 | $808.58 | 22.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 20 | $2,218 | $464.50 | 20.9% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 47 | 87 | $2,857 | $187.16 | 6.6% |
About Dr. Kenneth Ruby, MD
Dr. Kenneth Ruby, MD is a Urology healthcare provider based in Somerset, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063419133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Ruby, MD has received a total of $4,069 in payments from pharmaceutical and medical device companies, with $351.47 received in 2024. These payments were reported across 134 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,706).
As a Medicare-enrolled provider, Ruby has provided services to 10,626 Medicare beneficiaries, totaling 14,593 services with total Medicare billing of $854,637. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Somerset, KY
- Active Since 07/05/2005
- Last Updated 08/16/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1063419133
Products in Payments
- INTERSTIM (Device) $1,237
- UROLIFT (Device) $588.11
- XTANDI (Drug) $232.18
- XIAFLEX (Biological) $210.86
- GEMTESA (Drug) $109.01
- Olympus Cysto-Resection (Device) $108.96
- Nubeqa (Drug) $105.67
- MYRBETRIQ (Drug) $100.99
- Erleada (Drug) $98.72
- Xtandi (Drug) $92.80
- ORGOVYX (Drug) $84.12
- ELIGARD (Drug) $62.88
- Myrbetriq (Drug) $59.32
- LUPRON DEPOT (Drug) $47.25
- AMBICOR (Device) $44.02
- BMD-Inlay Optima Ureteral Stent (Device) $41.57
- Androgel (Drug) $39.83
- ZYTIGA (Drug) $35.99
- GENERAL - ERECTILE DYSFUNCTION (Device) $30.74
- BOTOX OAB (Drug) $28.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Somerset
Dr. Rajesh Bajpai, Md, Mch, MD, MCH
Urology — Payments: $22,227
Dr. Mohammad Bhatti, Md, MD
Urology — Payments: $4,646
Shawn Acino, Md Facs, MD FACS
Urology — Payments: $2,359
Dr. Cyril Kohrman, M.d, M.D
Urology
Dr. Ronald Coulombe, Md, MD
Urology